Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Polish Researchers Cite Rutherrin PDT for Brain Cancer

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Sep 14, 2023 10:59am

172 Views

Post# 35636014

RE:RE:RE:RE:RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain Cancer

I believe it is a small Canadian company on a small not so good exchange and investors are waiting for the goods before jumping in, i have heard that from several friends who i mentioned this stock to, so until something concrete(BTD,AA) dont think we have many new buyers coming aboard. Everyone here now is someone looking for a big hit before this breaks out, im speaking from the US side. Right now its like being in Vegas, playing slot machines that promise big payout

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant